临床试验

Transcranial Photobiomodulation for Bipolar Depression

NCT：NCT07510646 · NOT_YET_RECRUITING

NCT编号NCT07510646

状态NOT_YET_RECRUITING

开始日期2026-07-01

完成时间2027-07-01

简要摘要

This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the study and will either receive active treatment with the Vielight RX Gamma or sham (inactive device). They will be administered the devices in clinic 5days/week for 6 weeks. Changes in disease symptoms, cognitive function, pain, quality of life and rest EEG changes will be assessed.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。